Cargando…

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment

PURPOSE: To study resistance-associated substitutions using next-generation sequencing in Egyptian hepatitis C virus-infected patients failing direct-acting antiviral treatment. METHODS: The current study describes three cases of treatment failure in patients referred to Zagazig Viral Hepatitis Tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amer, Fatma, Yousif, Monkez M, Hammad, Noha M, Garcia-Cehic, Damir, Gregori, Josep, Rando-Segura, Ariadna, Nieto-Aponte, Leonardo, Esteban, Juan Ignacio, Rodriguez-Frias, Francisco, Quer, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750843/ https://www.ncbi.nlm.nih.gov/pubmed/31571936 http://dx.doi.org/10.2147/IDR.S214735

Ejemplares similares

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
por: von Massow, Georg, et al.
Publicado: (2019)

Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain
por: Dopico, Eva, et al.
Publicado: (2022)

Solved the enigma of pediatric severe acute hepatitis of unknown origin?
por: Rodriguez-Frias, Francisco, et al.
Publicado: (2023)

Ultra-Deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants
por: Gregori, Josep, et al.
Publicado: (2013)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
por: Llorens-Revull, Meritxell, et al.
Publicado: (2021)

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017)

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
por: Perales, Celia, et al.
Publicado: (2018)

ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs)
por: Ghanem, Samar, et al.
Publicado: (2023)

Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients
por: Andrés, Cristina, et al.
Publicado: (2020)

Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach
por: Rodríguez-Frías, Francisco, et al.
Publicado: (2021)

New real-time-PCR method to identify single point mutations in hepatitis C virus
por: Chen, Qian, et al.
Publicado: (2016)

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient
por: Gregori, Josep, et al.
Publicado: (2022)

Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing
por: Nieto-Aponte, Leonardo, et al.
Publicado: (2017)

The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants
por: Campos, Carolina, et al.
Publicado: (2022)

Bioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses
por: Ibañez-Lligoña, Marta, et al.
Publicado: (2023)

Host-dependent editing of SARS-CoV-2 in COVID-19 patients
por: Gregori, Josep, et al.
Publicado: (2021)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

Characterization of intra- and inter-host norovirus P2 genetic variability in linked individuals by amplicon sequencing
por: Sabrià, Aurora, et al.
Publicado: (2018)

Correction: Characterization of intra- and inter-host norovirus P2 genetic variability in linked individuals by amplicon sequencing
por: Sabrià, Aurora, et al.
Publicado: (2018)

Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: Implications for immunization policies
por: Sabrià, Aurora, et al.
Publicado: (2018)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Clinical Application of Estimating Hepatitis B Virus Quasispecies Complexity by Massive Sequencing: Correlation between Natural Evolution and On-Treatment Evolution
por: Homs, Maria, et al.
Publicado: (2014)

Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
por: Soria, María Eugenia, et al.
Publicado: (2018)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

Utility of the Cobas(®) Plasma Separation Card as a Sample Collection Device for Serological and Virological Diagnosis of Hepatitis C Virus Infection
por: Velásquez-Orozco, Fernando, et al.
Publicado: (2021)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
por: Roguljic, Hrvoje, et al.
Publicado: (2021)

Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients
por: García-García, Selene, et al.
Publicado: (2022)

HCV compliance and treatment success rates are higher with DAAs in structured HCV clinics compared to general hepatology clinics
por: Chehl, Navdeep, et al.
Publicado: (2019)

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
por: Maughan, A., et al.
Publicado: (2019)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
por: Casey, Julia L., et al.
Publicado: (2019)

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy
por: González, Carolina, et al.
Publicado: (2018)

Quantifying In-Host Quasispecies Evolution
por: Gregori, Josep, et al.
Publicado: (2023)

Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
por: Pacin-Ruiz, Beatriz, et al.
Publicado: (2022)

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects
por: Bono, Valeria, et al.
Publicado: (2022)

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Hosui, Atsushi, et al.
Publicado: (2021)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs
por: Ponnuvel, Suresh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b25potr3b1l607eq4jid1qojt3